Device Trial Radar · NCT02183727
L-C Ligament Versus Hamstring Autograft for Primary ACL Reconstruction
Last checked: Nov 20, 2026Latest source record: Nov 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
60
Planned (sponsor's estimate)
Start
Sep 2015
Primary completion
Jun 2020
Study completion Jul 2020
Sponsor
- Lead sponsor
- Soft Tissue Regeneration, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 8, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare safety and efficacy outcomes of the L-C Ligament versus Hamstring Autograft for treatment of acute rupture of the ACL.
Conditions
- Acute Ruptures of the Anterior Cruciate Ligament
Interventions
L-C LigamentDevice
The L-C Ligament is a bioresorbable, three-dimensional (3-D) braided scaffold made from poly L-lactic acid (PLLA) fiber. One device is used to replace the ACL. The L-C Ligament is an interventional device. The L-C Ligament is comprised of three regions: (1) The femoral tunnel attachment site, (2) The ligament region (intra-articular zone), and (3) The tibial tunnel attachment site. For several months after surgery, the L-C Ligament replaces the function of the ACL. During this time, ligament tissue regenerates within and around the L-C Ligament, which is slowly absorbed and replaced by the ACL.
Hamstring AutograftProcedure
The gold-standard treatment for ACL reconstruction is autograft tissue. Autograft is a piece of tendon harvested from another part of the patient's body, such as the hamstring or kneecap. In this study, the hamstring tendon from the back of the thigh of the injured (target) leg will be harvested and surgically transferred to replace the torn ACL. The attachment of the autologous tendon in the femoral and tibial bone tunnels will utilize techniques that are similar to those for the L-C Ligament. Over time the replacement tendon resorbs and a new ACL is regenerated.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Graft FailureTime frame: 12 Months
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Isala Klinieken
Zwolle, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.